Compare · CELZ vs NU
CELZ vs NU
Side-by-side comparison of Creative Medical Technology Holdings Inc. (CELZ) and Nu Holdings Ltd. (NU): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CELZ and NU operate in Finance: Consumer Services (Finance), so they compete in similar markets.
- NU is the larger of the two at $68.42B, about 17808.3x CELZ ($3.8M).
- Over the past year, CELZ is down 71.5% and NU is up 10.3% - NU leads by 81.8 points.
- NU has been more active in the news (10 items in the past 4 weeks vs 7 for CELZ).
- NU has more recent analyst coverage (25 ratings vs 1 for CELZ).
- Company
- Creative Medical Technology Holdings Inc.
- Nu Holdings Ltd.
- Price
- $0.81-0.47%
- $14.08-0.78%
- Market cap
- $3.8M
- $68.42B
- 1M return
- -59.90%
- +13.00%
- 1Y return
- -71.48%
- +10.34%
- Industry
- Finance: Consumer Services
- Finance: Consumer Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 7
- 10
- Recent ratings
- 1
- 25
Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem for the treatment of erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine for the treatment of chronic lower back pain; Amniostem for the treatment of strokes, radiation, toxicity, and glioma; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona.
Nu Holdings Ltd.
Nu Holdings Ltd. operates in the technology industry. The company was incorporated in 2016 and is based in Grand Cayman, Cayman Islands.
Latest CELZ
- SEC Form S-3 filed by Creative Medical Technology Holdings Inc.
- SEC Form DEF 14A filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
- SEC Form PRE 14A filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Issues Mid-Year Update
- Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds
- SEC Form RW filed by Creative Medical Technology Holdings Inc.
- Amendment: SEC Form S-1/A filed by Creative Medical Technology Holdings Inc.
- SEC Form S-1 filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain
Latest NU
- Nubank Strengthens Its Brazil Operation With a New Banking License
- SEC Form 6-K filed by Nu Holdings Ltd.
- Chief Financial Officer Livingston Robert Philip was granted 2,194,587 units of Class A ordinary shares (SEC Form 4)
- SEC Form 3 filed by new insider Livingston Robert Philip
- Nu Mexico Receives Authorization to Begin Operations as a Bank
- SEC Form 6-K filed by Nu Holdings Ltd.
- SEC Form 6-K filed by Nu Holdings Ltd.
- SEC Form 6-K filed by Nu Holdings Ltd.
- SEC Form 6-K filed by Nu Holdings Ltd.
- Data Nubank: Nubank Leads as Brazilians' Primary Financial Institution and Has Already Banked 31.5 Million People